Navigation Links
Story ideas from Molecular and Cellular Proteomics
Date:1/22/2008

Searching for Amyloid Interactions

Researchers have undertaken a large-scale investigation into the molecular environment of the amyloid precursor protein (APP), a protein centrally associated with Alzheimer's disease.

A defining hallmark of Alzheimer's is the extracellular accumulation of amyloid plaques in the diseased brain. These plaques arise from the cleavage of APP, which generates short, sticky fragments called amyloid B-peptides. Despite intense research efforts, however, the function of APP remains enigmatic and only a few proteins are known to interact with it.

Gerold Schmitt-Ulms and colleagues employed a technique called 'time-controlled transcardiac perfusion cross-linking" to uncover more APP-interacting proteins. They pumped a chemical through a mouse's body that would permanently cross-link any proteins that were in close proximity. They could then fish out APP from the brain and study what it was linked to.

From their perfusion, Schmitt-Ulms and colleagues confirmed eight previously reported APP interactions and also identified over 30 new, potentially interacting proteins. They also mapped the interactions of two proteins related to APP that are not known to cause disease, to sense which interactions the three related proteins had in common and which were APP-specific; interestingly the majority of the potential binding partners were specific to APP.

This work constitutes the most comprehensive analysis of the APP interactome to date and may finally shed light on the functional roles of APP in the brain. The researchers believe further investigations of these new interactions may reveal an "Achilles' heel" in the biology of APP that can be exploited for diagnosis or therapy.

CORRESPONDING AUTHOR: Gerold Schmitt-Ulms, the Centre for Research in Neurodegenerative Diseases at the University of Toronto, Ontario; Phone: (416) 946-0066, email: g.schmittulms@utoronto.ca


Low Variation in Platelet Protein Expression within the Elderly

The variation in human platelets in the elderly population is not significantly large, report researchers in a study that has strong implications for clinical biomarker research.

The onset or progression of diseases like cancer is accompanied by changes in the expression of specific proteins. These proteins could be used as biomarkers to diagnose patients early or track therapy progression. However, identifying clinical biomarkers requires knowing the extent of natural protein variation in the population, which arises from a combination of factors like age, gender, and genetic background.

Rudolf Oehler and colleagues examined the platelet protein variation in 20 individuals aged 56-100, an age group at higher for many diseases. Interestingly, while their analysis had a 7% variation from technical accuracy, the total variation was only 18%, although a few proteins did show dramatic differences.

Since the variation of protein expression in normal platelets is fairly low, any changes in protein expression associated with disease will likely also be small (i.e. a low expression range in a healthy population means you don't need big changes to perturb the system).

Platelets play a key role in maintaining the health of our blood and since they're easy to extract they may be a valuable source for protein biomarkers. Due to the naturally low variation, though, Oehler and colleagues note that finding these biomarkers requires highly sensitive and accurate equipment.

CORRESPONDING AUTHOR: Rudolf Oehler, The Medical University of Vienna, Austria; Phone: 43-1-40400-6979; E-mail: rudolf.oehler@meduniwien.ac.at


'/>"/>

Contact: Nick Zagorski
nzagorski@asbmb.org
American Society for Biochemistry and Molecular Biology
Source:Eurekalert  

Related medicine news :

1. Dr. Paul Bandt Celebrates 35th Anniversary With Desert Radiologists and a History of Healthcare in Las Vegas
2. Blue Cross Blue Shield of Michigan Corrects News Story about Drug Coverage Announcement
3. Family History Has Strong Effect on Cardiac Risk
4. SEIU Endorses AB 8, An Opportunity to Make History
5. Story ideas from molecular & cellular proteomics
6. Update on Jill Finley Story, Coma Survivor
7. Story tips for journalists
8. Family history of alcoholism affects response to drug used to treat heavy drinking
9. ABC TV San Francisco Features Canine Cancer Research Story: Saving Our Dogs, Helping Humans Beat Cancer - Work at Morris Animal Foundation, UC-Davis
10. Story Reveals How Isabel and Her Family Learn About Bone Health and Osteoporosis
11. Every Baby Has a Story Campaign Tours the Nation for March of Dimes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Story ideas from Molecular and Cellular Proteomics
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and ... out for each of his children. “The Angel” is the creation of published author, ... New York City, and impassioned writer. , When asked of her new book, Marjorie ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “I Forgive You”: a fine examination of ... Forgive You” is the creation of published author, Stephen Miller, who, for over ten long ... gracefully given to him. Born in Trinidad and Tobago, he has been serving the Lord ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Christmas in Suffolk”: a ... author, Sara Seymour, who lives in Lafayette, Indiana where she works in a daycare ... coffees and writes. , Published by Christian Faith Publishing, Sara Seymour’s new book is ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Knowledge is God’s Lighthouse”: ... by faith. “Knowledge is God’s Lighthouse” is the creation of published author, Gene Gaapf, ... and poetry collections. , “I have been writing since high school and have ...
(Date:1/20/2017)... ... January 20, 2017 , ... “God's Miracle Man: Against All ... is the creation of published author, Keith C. A. Tucker, son of Minister Delores ... World Outreach pastured by Reverend Mark Hardy , “While sitting up in bed, I ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... 20, 2017 Research and Markets has ... Type ([CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive ... Segment Forecasts, 2013 - 2024" report to their offering. ... The global clinical ... 2024 Introduction of innovative solutions on the grounds of ...
(Date:1/20/2017)... , Jan. 20, 2017  Palladian Health, a ... announced the launch of an opioid management program ... on opioids and helps stem the growing tide ... prescribed to treat chronic non-cancer pain (back pain, ... risks and lack of evidence regarding long-term effectiveness. ...
(Date:1/19/2017)... YORK , Jan. 19, 2017 ... USD 233.7 billion by 2025, according to a ... market is anticipated to be predominantly driven by ... resulting into the large-scale production of new and ... the influx of drugs at an unprecedented rate ...
Breaking Medicine Technology: